Humana (NYSE:HUM) Insider Joseph Ventura Sells 5,495 Shares of Company Stock

Humana Inc. (NYSE:HUM) insider Joseph Ventura sold 5,495 shares of Humana stock in a transaction on Monday, November 9th. The shares were sold at an average price of $433.85, for a total value of $2,384,005.75. Following the completion of the transaction, the insider owned 21,910 shares of the company’s stock, valued at approximately $9,505,653.50. This trade represents a 20.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Humana Stock Performance

NYSE:HUM opened at $442.67 on Friday. The business’s fifty day moving average is $407.64 and its 200 day moving average is $315.70. The firm has a market cap of $53.17 billion, a price-to-earnings ratio of 33.66, a PEG ratio of 2.12 and a beta of 0.65. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.74 and a current ratio of 1.65. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $456.50.

Humana (NYSE:HUM) last issued its earnings results on Friday, November 6th. The insurance provider reported ($0.70) EPS for the quarter, topping the consensus estimate of ($1.00) by $0.30. The business had revenue of $41.16 billion during the quarter, compared to the consensus estimate of $40.87 billion. Humana had a return on equity of 8.50% and a net margin of 0.81%. The firm’s revenue was up 26.1% compared to the same quarter last year. During the same quarter last year, the company earned $3.24 EPS. Humana has set its FY 2026 guidance at 9.500- EPS. Research analysts predict that Humana Inc. will post 9.69 EPS for the current year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 29th. Stockholders of record on Thursday, December 24th will be given a $0.8850 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date is Thursday, December 24th. Humana’s dividend payout ratio (DPR) is 34.44%.

Wall Street Analyst Weigh In

HUM has been the subject of several recent analyst reports. Barclays boosted their price objective on shares of Humana from $582.00 to $587.00 and gave the company an “overweight” rating in a research note on Monday. Jefferies Financial Group reiterated a “buy” rating and issued a $420.00 target price on shares of Humana in a research note on Friday, November 6th. Lake Street Capital initiated coverage on shares of Humana in a report on Thursday, July 30th. They issued a “buy” rating for the company. Guggenheim boosted their price target on shares of Humana from $471.00 to $521.00 and gave the company a “buy” rating in a research report on Monday. Finally, Wolfe Research reaffirmed an “outperform” rating and issued a $450.00 price target on shares of Humana in a report on Monday, August 24th. One investment analyst has rated the stock with a Strong Buy rating, twenty-one have issued a Buy rating, nine have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $476.52.

Latest Humana News

These are some of the HUM news items that stood out recently:

• Positive Sentiment: Humana’s fair value estimate was raised following its Medicare star ratings and third-quarter earnings beat, reinforcing the view that operating results and ratings momentum could support the shares. Yahoo Finance article
• Neutral Sentiment: TD Cowen raised its price target to $430 from $370 but maintained a “hold” rating; its target is below the cited share price, signaling a more cautious view than other recent analyst calls.
• Negative Sentiment: A law firm invited Humana shareholders to discuss their rights concerning a potential fiduciary-duty matter. The notice provides no specific findings, so it indicates a legal inquiry rather than established wrongdoing. PR Newswire notice

Institutional Investors Weigh In On Humana

Several hedge funds have recently bought and sold shares of the stock. Johnson Financial Group Inc. purchased a new stake in shares of Humana during the 2nd quarter valued at $26,000. Trust Co. of Vermont bought a new stake in shares of Humana during the 2nd quarter worth $28,000. Bogart Wealth LLC lifted its holdings in shares of Humana by 192.0% during the 2nd quarter. Bogart Wealth LLC now owns 73 shares of the insurance provider’s stock worth $29,000 after acquiring an additional 48 shares during the last quarter. MidFirst Bank purchased a new position in Humana in the second quarter worth $35,000. Finally, Global Assets Advisory LLC purchased a new position in Humana in the first quarter worth $38,000. 92.38% of the stock is currently owned by institutional investors.

About Humana

Humana Inc. is a U.S. health and wellness company that provides health insurance and healthcare services. Its insurance offerings include Medicare Advantage, Medicare Supplement and prescription drug plans, as well as Medicaid and employer-sponsored plans. The company also provides care through CenterWell, its healthcare services brand, which includes primary care, home health and pharmacy services. Its insurance and care offerings are available in markets across the United States, with availability varying by product and location.